Tunghai University Institutional Repository:Item 310901/31786
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 21921/27947 (78%)
造访人次 : 4217013      在线人数 : 400
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://140.128.103.80:8080/handle/310901/31786


    题名: 加入短期反應訊息於多組治療存活時間比較之適應性隨機指派設計
    其它题名: Adaptive Randomization for Multiarm Survival Clinical Trials Using Short-Term Response Information
    作者: 涂瑞銓
    TU,JUI-CHUAN
    贡献者: 張玉媚
    CHANG,YU-MEI
    統計學系
    关键词: 適應性隨機指派;白血病;反應率;馬可夫鏈蒙地卡羅;替代終點
    adaptively randomization;leukemia;response rate;Markov chain Monte Carlo;surrogate endpoint
    日期: 2019
    上传时间: 2019-12-16T06:28:37Z (UTC)
    摘要: 在第二期臨床試驗時,我們不希望花費太多的時間和資源,因此我們需要有效率的隨機指派方法,挑出可能有療效的治療方法,趕緊進到第三期試驗做藥效的確認。傳統上使用存活時間當作主要終點(primary endpoint),將花費太長的時間,無法有效地在試驗期間適應性地隨機指派不同治療給病人,然而使用短期的療效(例如腫瘤反應率)當作隨機指派的依據,可能病人短期療效好,但存活時間卻不長。由於主要的目的是希望新的治療可以使病人存活時間延長,因此Huang等人(2009)等人使用短期反應率的訊息來加速存活時間適應性隨機指派臨床試驗。本論文將推廣Huang等人(2009)的方法由兩組治療的比較推廣至多組比較,並將存活時間為指數分配的假設推廣至韋伯分配。由於Huang等人(2009)提出的模型是每一個世代(cohort)一位病人進案時都進行期中分析,下一個進到試驗的病人則是根據修正的隨機指派之機率進行隨機指派,為節省時間,我們考慮使用每一個世代為五個人進到試驗後再進行期中分析,並比較每一個病人和每五個病人的模擬結果。
    We usually don’t want to waste substantial amount of time and resources in phase two clinical trials, therefore we need effective methods of randomization, so that we can chose a potential treatment on survival, and confirm its benefit in phase three trial quickly. Traditionally, using survival time as a primary endpoint, takes a long period of time to assign patients to different groups ineffectively during the adaptive-randomization trails. However, using short-term efficacy (e.g. tumor response rate) as a primary endpoint, may show that patients have good efficacy shortly, but do not have long period of survival time. Owing to prolonging survival time is a common goal of a better treatment, Huang et al. (2009) proposed a model which used short-term response information to facility adaptive randomization for survival clinical trials. In this article, we extend the method which Huang et al. (2009) proposed to multi-arms clinical trials. Moreover, we assume that the survival time of patients is following the mixture Weibull distribution. In addition, since the model of Huang et al. (2009) proposed conduct interim analyses each cohort of one patient, and following patient randomize into the trial is based on the revised probability of adaptive randomization. In order to save time, we consider to conduct interim analyses each cohort of five patients, then compare the respective simulation results.
    显示于类别:[統計學系所] 碩博士論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    107THU00337011-001.pdf1674KbAdobe PDF179检视/开启


    在THUIR中所有的数据项都受到原著作权保护.


    本網站之東海大學機構典藏數位內容,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈